Halozyme Therapeutics: H.C. Wainwright raises target price to $130 from $115
HALO•H.C. Wainwright raised its target price for Halozyme Therapeutics to $130 from $115.
Related News
AeroVironment unit VideoRay joins AEVEX-led Navy mine countermeasure prototype team
AVAV•
Astera Labs showcases PCIe 7 copper and optical demos at Open Compute Project Global Summit
ALAB•
Kodiak AI and Charger USA launch autonomous trucking between Dallas and Laredo
KDK•
Frontdoor sets conference call for third-quarter results release
FTDR•
Imunon CEO Stacy Lindborg joins Maxim Growth Summit oncology panel
IMNN•